Press Releases

SurgiBot TM system FDA 510(k) filing on track for mid-2015 submission RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix , Inc. (NYSE MKT: TRXC ), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced the appointment of William N. Kelley , M.D.

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. ( NYSE MKT : TRXC), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced that Richard Mueller , its Chief Operating Officer, resigned his

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT:TRXC), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced its operating and financial results for the third quarter 2014.

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. ( NYSE MKT : TRXC) announced today that Todd M. Pope , President and Chief Executive Officer, and Joseph P. Slattery , Executive Vice President and Chief Financial Officer, will present at the Stifel 2014 Healthcare Conference at

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. ( NYSE MKT : TRXC) announced today that it plans to release third quarter 2014 financial and operating results before the market opens on Thursday, November 6, 2014 . Todd M. Pope , Chief Executive Officer and Joseph P.

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. ( NYSE MKT : TRXC), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced that it has expanded its existing agreement with Oxford Finance LLC

MONTREAL --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced the broadcast of a successful sleeve gastrectomy surgery by Dr.

Remain on track to file SurgiBot TM FDA 510(k) before year-end 2014 Completed sale of 14.1 million shares of common stock and raised $52.5 million , net of issuance costs Completed uplisting to NYSE MKT in April 2014 Launched fully flexible advanced energy device RESEARCH TRIANGLE PARK, N.C.

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT:TRXC) announced today that it plans to release second quarter 2014 financial and operating results after the market closes on Wednesday, August 6, 2014 . Todd M. Pope , Chief Executive Officer and Joseph P.